• Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

    2 monthes ago - By News Medical

    A study has shown that hybrid day-night closed-loop insulin delivery systems are the most effective way of controlling blood sugar levels in type 1 diabetes.
    Read more ...

     

  • Hybrid Closed-Loop No Cure for Diabetes Despite Promising Data

    2 monthes ago - By Medscape

    Partially automated insulin delivery system increases time spent in target glucose range and minimizes hypoglycemia in patients with type 1 diabetes who have suboptimal control, but is still far from a cure.
    Medscape Medical News
    Read more ...

     

  • Top stories in endocrinology: Dapaglifozin safe for CV outcomes, liver enzymes foreshadow type 2 diabetes

    2 monthes ago - By Healio

    Among the top stories in endocrinology this week were phase 3 results of dapagliflozin in a CV outcomes trial, a study that concluded liver enzymes foretold type 2 diabetes risk and a report that showed increased use of medications associated with osteoporosis risk.
    Additional top stories included a study that found exposure to bisphenol A, or BPA, even at a dose that U.S. regulatory agencies declared safe, may alter change human glucose-stimulated insulin response and findings that some patients with primary aldosteronism undergoing adrenal vein sampling might be exposed to “fairly high”
    Read more ...

     

  • Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

    2 monthes ago - By News Medical

    New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.
    Read more ...

     

  • Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

    2 monthes ago - By News Medical

    New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.
    Read more ...